A catheter or other invasive/implant device (40;52) intended for relatively long term use, of the order of a day or more, in a patient's body is provided with an electric field generator (48;53) to inhibit bacterial attachment and colonization on and adjacent the device/body interface. The generator can involve application to the device of electret material (53) or an electrode (48) in or for connection with an electrical circuit (47,50,51). The field is preferably unidirectionally negative and also continuous and constant, but pulsatile, alternating and other field forms are possible.
|
9. A method of reducing infection arising as a result of the presence of a device being at least partially placed within a patient's body, said method comprising the steps of:
providing a field generating means comprising an electret material for generating a persistent negative electric field around said device for repelling bacteria; and while said device is at least partially placed within said body, repelling said bacteria by generating said negative persistent electric field for the order of at least a day, whereby bacterial attachment and colonization in and adjacent the device the device/body interface is inhibited.
11. A method of reducing infection arising as a result of the presence of a device being at least partially placed within a patient's body, said method comprising the steps of:
providing a field generating means comprising an electret material for generating a persistent negative electric field around said device for repelling bacteria; and while said device is at least partially within said body, repelling said bacteria by generating said negative persistent electric field for the order of at least a day as a sole electrical measure for inhibiting bacterial attachment and colonization in and adjacent the device/body interface.
1. A method of reducing infection arising as a result of a device being at least partially placed within a patient's body, said method comprising the steps of:
providing a field generating means comprising two electrodes and a separate power source connected between said electrodes for generating a persistent negative electric field around said device for repelling bacteria; and while said device is at least partially placed within said body, repelling said bacteria by generating said persistent negative electric field for the order of at least a day, whereby bacterial attachment and colonization in and adjacent the device/body interface is inhibited.
13. A method of reducing infection arising as a result of the presence of a device being at least partially placed within a patient's body, said method comprising the steps of:
providing a field generating means comprising two electrodes and a separate power source connected between said electrodes for generating a persistent negative electric field extending around said device for repelling bacteria; and while said device is at least partially placed within said body, repelling said bacteria by generating said negative persistent electric field for the order of at least a day as a sole electrical measure for inhibiting bacterial attachment and colonization in and adjacent the device/body interface.
2. A method according to
3. A method according to
5. A method according to
7. A method according to
placing said one electrode within said body together with said device to generate said field, and placing said other electrode on the skin of said body.
8. A method according to
10. A method according to
12. A method according to
14. A method according to
15. A method according to
17. A method according to
|
This is a continuation of application Ser. No. 07/554,909, filed Jul. 16, 1990, now abandoned, which is a Rule 62 continuation of U.S. Ser. No. 07/363,478 filed Jun. 7, 1989, now abandoned.
This invention concerns medical devices intended for relatively long term use, of the order of a day or more, in a location extending at least partially within a patient's body. Such devices include a variety of kinds, such as catheters, cannulae, shunts and orthopaedic endoprostheses, having a similar variety of primary functions and varyingly intended for deployment in a temporary or permanent role.
A fundamental problem associated with the use of such devices is that of infection. Infection in these circumstances is thought to involve the attachment of bacteria on the device surface which interfaces with the patient's body tissue and subsequent bacterial colonisation on and in the immediate vicinity of such surface. This situation is discussed, for example, in an article entitled "Intravascular line associated infections--prospects for prevention" by Dr. T. S. J. Elliott, presented at a symposium on "New Perspectives on Staphylococcus Infections" held September 1986, Lancashire, and thereafter published in 1987 in a booklet under the latter title by Medicom (UK) Limited. It will be seen from this article that various proposals for combative measures have yet to be established as satisfactory.
An object of the present invention is to reduce this infection problem by way of a measure involving, in general terms, provision of the device with means to generate an electric field over its interface surface, which field acts to inhibit bacterial attachment and colonisation on and adjacent that surface.
In one form of the invention the generating means comprises appropriately charged electret material applied over the device and so itself defines the interface surface, or such material applied in some other suitable manner.
In another form of the invention the generating means comprises a conductor for or in connection with an electrical circuit, the conductor being supported by the device and the circuit being operable to generate the appropriate field by way of the conductor. The conductor can be supported as a coating over the device and so itself define the interface surface, or it can be embedded as a wire or other configuration within the device suitably, in this event, to follow the outer surface shape of the device.
As so far developed the electric field is preferably negative to inhibit bacterial attachment by repulsion, the bacteria of concern commonly having negative surface charge. Such a field can also interfere with the bacterial charge, which charge plays a significant role in the attachment process.
Also, as so far developed the field is preferably continuously maintained in a substantially constant manner, but there is no reason to suppose that a pulsatile or otherwise varying negative field cannot be used to effect the desired action.
Indeed, it is not at present considered that the field should necessarily be unidirectionally negative. A field of alternating polarity can interfere with the ionic exchange process between the bacterial cell wall and surrounding medium and so act to inhibit colonisation. Moreover, an alternating field for this purpose need not necessarily be symmetrically cyclic, but can be asymmetrical.
Also, it is considered that the field of the invention can act against infection in other ways. For example, electroporation can be caused in cells subjected to the field and this could facilitate the action of drugs and/or natural immune response mechanisms on bacteria in the vicinity of the device. Moreover, to the extent that drugs, such as antibiotics, often exhibit a positive surface charge they can be beneficially attracted to and retained in the same vicinity.
For further clarification of the invention, reference is made to the accompanying drawings in which:
FIGS. 1-3 diagrammatically illustrate respectively different experiments conducted during development of the invention, and
FIGS. 4-6 similarly illustrate, by way of example, respectively different forms of device according to the invention.
In the experiment of FIG. 1 a stainless steel wire 10 was located along a plastics cannula 11 with a free end portion of the wire being wound around the tip portion of the cannula to form an electrode 12. The other end of the wire 10 was connected to the negative terminal of a constant current generator 13, a further stainless steel wire 14 being connected to the positive terminal of the generator and extending to an "indifferent" electrode 15 at its free end. The cannula tip plus its electrode 12 was placed, with the indifferent electrode 15, in mutually spaced manner in a turbid broth 16 of Staphylococcus epidermidis, at about 107 cfu ml-1, the broth being retained within the confines of an O-ring 17 mounted on a glass slide 18. The generator 13 was then operated to pass a small current of 1-10 μA between the electrodes for a period of 1-1.5 hours. After such operation clear areas appeared around the cannula and its electrode, that is to say there were insufficient bacteria in this area to make it turbid, and there were no bacteria visible on the cannula surface. At the same time the broth closely around the indifferent electrode appeared more turbid than that further spaced.
For comparative purposes the same arrangement was set up and left for 1.5 hours without generator operation and, in the result the broth remained evenly turbid.
In the experiment of FIG. 2 the same arrangement of slide, O-ring and broth was used as in FIG. 1 but with the other elements changed. In this case a D.C. source 20 had respective PVC insulated wires 21 and 22 connected to its terminals, the free end portions of these wires being located to pass through the broth in mutually spaced manner before securement to the slide with silicon sealant 23. Operation with the source applying a potential of about 100 V to the wires was considered effective to induce a small surface charge on the insulation surfaces of the wires. This charge was sufficient on the negative wire insulation to repel bacteria judged by the appearance of a clear zone in the broth around this wire.
In the experiment of FIG. 3 a petri dish 30 holding agar 31 was flooded with a broth of Staphylococcus epidermidis and allowed to dry such that about 106 cfu bacteria were deposited, this being insufficient to give visible turbidity. Thereafter two pairs of hypodermic needles 32 were inserted in the agar in like mutually spaced manner to serve as electrodes. One such pair of electrodes was connected by wires 33 to respective terminals of a constant current source 34, while the other pair were left unconnected as control electrodes, and the dish incubated overnight at 37°C with the source operating at about 10 μA. In the result the bacteria grew to form a confluent turbid lawn over the agar surface except for a clear zone 35 of about 3 mm diameter around the electrode connected to the source negative terminal, in which zone there was no bacterial growth.
The device of FIG. 4 is a catheter 40 comprising an elongate tubular body 41 of plastics material. The distal end portion or tip has a rounded closed end 42, while the proximal end portion terminates in a socket 43 of Luer or other form. The catheter is of double lumen form, having a larger lumen 44 communicating the socket 43 with apertures 45 in the wall of the tip for fluid transmission through the catheter, and a smaller lumen 46 closed at its ends. A wire 47 extends through the smaller lumen 46 and at its ends penetrates the catheter wall in sealed manner. The distal end portion for entry into a patient has an external electrode coating 48 of metal, carbon or other conductive material connected with the adjacent end of wire 47 and at the proximal end portion the end of the wire is connected with an electrical terminal 49.
In use the catheter will be connected by way of terminal 49 with the negative terminal of a constant current generator 50, suitably powered by a 1.5 V battery to generate an output of 1-10 μA, the generator having its positive terminal connected to a skin electrode 51 of conventional form, such as used in ECG monitoring and the like, for application to the patient.
The device of FIG. 5 comprises a simple single lumen catheter 52 having, over its distal end portion for entry in a patient, a coating 53 of persistent negatively-charged electret material. The charge on this material need only be such as to produce an electric field extending from the catheter up to a few tenths of 1 mm: the body, being an ionic conductor, will not allow a more extensive field to be established.
The device of FIG. 6 is similar to that of FIG. 4 except that in this case the distal electrode, denoted at 54, is embedded within the material of the catheter body to follow the outer surface shape of the body. This electrode is subjected to a potential of about 100 V by a battery-powered dc-to-dc converter having a current output limitation facility set no higher than 1 μA for patient safety in the event of breakdown of the catheter material insulation around the electrode during use.
Byrne, Phillip O., Elliott, Thomas S. J.
Patent | Priority | Assignee | Title |
10278521, | Oct 25 2012 | UNIVERSITAT POMPEU FABRA | System for preventing bacterial infections in needle trajectories |
10299882, | Mar 14 2012 | Armour Technologies, Inc. | Sterile site apparatus, system, and method of using the same |
11147650, | Mar 14 2012 | Armour Technologies, Inc. | Sterile site apparatus, system, and method of using the same |
5295955, | Feb 14 1992 | AMT, Inc. | Method and apparatus for microwave aided liposuction |
5304120, | Jul 01 1992 | GENETRONICS, INC | Electroporation method and apparatus for insertion of drugs and genes into endothelial cells |
5352192, | Apr 27 1991 | BRITISH TECHNOLOGY GROUP PLC | Medical device |
5401239, | Mar 11 1993 | Physion s.r.l. | Electromotive treatment of catheter-rerelated infections |
5498248, | Nov 12 1992 | BRIDGE BLOOD TECHNOLOGIES LLC, NEW YORK LIMITED LIABILITY COMPANY | Iontophoretic structure for medical devices |
5507724, | Jul 01 1992 | Genetronics, Inc. | Electroporation and iontophoresis apparatus and method for insertion of drugs and genes into cells |
5531679, | Mar 14 1994 | Fluidic infusion system for catheter or probe | |
5741224, | Apr 16 1996 | BRIDGE BLOOD TECHNOLOGIES LLC, NEW YORK LIMITED LIABILITY COMPANY | Iontophoretic material |
5759564, | Apr 16 1996 | BRIDGE BLOOD TECHNOLOGIES LLC, NEW YORK LIMITED LIABILITY COMPANY | Iontophoretic material |
6060000, | Nov 12 1992 | IMPLEMED, INC | Iontophoretic material containing carbon and metal granules |
6119037, | Jun 06 1995 | Board of Regents, The University of Texas System | Electrode system in iontophoretic treatment devices |
6287484, | Nov 12 1992 | IMPLEMED, INC | Iontophoretic material |
6366807, | Jun 06 1995 | Board of Regents, The University of Texas System | Electrode system in iontophoretic treatment devices |
7122027, | May 23 2002 | Medtronic, Inc | Implantable medical device with controllable gaseous agent release system |
9615884, | Mar 14 2012 | ARMOUR TECHNOLOGIES, INC | Sterile site apparatus, system, and method of using the same |
Patent | Priority | Assignee | Title |
2121875, | |||
2276623, | |||
2456909, | |||
2482507, | |||
2655922, | |||
3968790, | Feb 26 1975 | Rikagaku Kenkyusho | Electret method of promoting callus formation in regeneration of bones |
4027393, | Sep 19 1975 | MDT CORPORATION, A DE CORP ; SANTA BARBARA RESEARCH CENTER, GOLETA, CA , A CA CORP | Method of in vivo sterilization of surgical implantables |
4314554, | Jul 16 1979 | Tissue growth control apparatus and method | |
4411648, | Jun 11 1981 | Board of Regents, The University of Texas System | Iontophoretic catheter device |
4528265, | May 11 1982 | FLICK, ARTHUR BARTHOLOMEW | Processes and products involving cell modification |
4569673, | Jan 12 1984 | BRIDGE BLOOD TECHNOLOGIES LLC, NEW YORK LIMITED LIABILITY COMPANY | Bacterial barrier for indwelling catheters and other medical devices |
4572194, | Oct 05 1982 | Device for therapy of the human or animal body | |
4846179, | Jun 08 1987 | Electro-medical method and apparatus for treating folliculitis and cutaneous infected conditions | |
4886075, | Dec 02 1988 | Thermoelectric ion generator for endodontic therapy | |
DE3240838A1, | |||
EP134845, | |||
EP140854, | |||
EP140980, | |||
GB1286075, | |||
GB2195253A, | |||
GB230967, | |||
WO8607543, | |||
WO8902284, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Oct 12 1989 | ELLIOTT, THOMAS S J | NATIONAL RESEARCH DEVELOPMENT CORPORATION, A BRITISH CORP | ASSIGNMENT OF ASSIGNORS INTEREST | 006098 | /0457 | |
Oct 12 1989 | BYRNE, PHILLIP O | NATIONAL RESEARCH DEVELOPMENT CORPORATION, A BRITISH CORP | ASSIGNMENT OF ASSIGNORS INTEREST | 006098 | /0457 | |
Nov 26 1991 | National Research Development Corporation | (assignment on the face of the patent) | / | |||
Jul 09 1992 | National Research Development Corporation | British Technology Group Limited | ASSIGNMENT OF ASSIGNORS INTEREST | 006243 | /0136 | |
Jun 28 2011 | BTG International Limited | BTG International Limited | CHANGE OF ADDRESS CERTIFICATE | 033134 | /0336 |
Date | Maintenance Fee Events |
Apr 01 1996 | M183: Payment of Maintenance Fee, 4th Year, Large Entity. |
Mar 17 2000 | M184: Payment of Maintenance Fee, 8th Year, Large Entity. |
Apr 28 2004 | REM: Maintenance Fee Reminder Mailed. |
Oct 13 2004 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Oct 13 1995 | 4 years fee payment window open |
Apr 13 1996 | 6 months grace period start (w surcharge) |
Oct 13 1996 | patent expiry (for year 4) |
Oct 13 1998 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 13 1999 | 8 years fee payment window open |
Apr 13 2000 | 6 months grace period start (w surcharge) |
Oct 13 2000 | patent expiry (for year 8) |
Oct 13 2002 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 13 2003 | 12 years fee payment window open |
Apr 13 2004 | 6 months grace period start (w surcharge) |
Oct 13 2004 | patent expiry (for year 12) |
Oct 13 2006 | 2 years to revive unintentionally abandoned end. (for year 12) |